Year in Review: Updates in Antibody-Drug Conjugates for Treating Advanced NSCLC - Episode 2

T-DXd in HER2 Mutated Advanced NSCLC

,

Benjamin Levy, MD, reviews clinical data on T-DXd in HER2 mutated advanced NSCLC and their practical implications.